Prosecution Insights
Last updated: April 19, 2026
Application No. 17/789,819

CURABLE COMPOSITION AND INK FOR INK-JET PRINTING

Non-Final OA §103
Filed
Jun 29, 2022
Examiner
BERRO, ADAM JOSEPH
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shin-Etsu Chemical Co. Ltd.
OA Round
1 (Non-Final)
59%
Grant Probability
Moderate
1-2
OA Rounds
3y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allow Rate
23 granted / 39 resolved
-6.0% vs TC avg
Strong +53% interview lift
Without
With
+53.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
61 currently pending
Career history
100
Total Applications
across all art units

Statute-Specific Performance

§101
2.0%
-38.0% vs TC avg
§103
57.1%
+17.1% vs TC avg
§102
10.3%
-29.7% vs TC avg
§112
23.0%
-17.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 39 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-6 are rejected under 35 U.S.C. 103 as being unpatentable over Kashiwagi (US 20040127613, US Document #2 from IDS dated 6/29/2022). Regarding Claim 1, Kashiwagi teaches a composition containing the following structure: PNG media_image1.png 120 530 media_image1.png Greyscale in which k (equivalent to m of the instant claim) is an integer from 1 to 4, R (equivalent to R3 of the instant claim) is hydrogen or methyl, l (equivalent to a of the instant claim) is an integer from preferably between 2 and 200 and m (equivalent to b of the instant claim) is an integer between 0 and 200 (Paragraph 31). These ranges overlap with the ranges of the instant claim. One of ordinary skill in the art, seeking to reduce the viscosity of the resulting composition, would seek to limit the molecular weight of the oligomeric/polymeric siloxane and, by extension, the number of repeat units of the siloxane. As such, it would have been obvious to have limited the sum of the monomer units. It also would have been obvious to have selected the overlapping portion of the ranges because selection of the overlapping portion of ranges has been held to be a prima facie case of obviousness. See MPEP 2144/05.I. Kashiwagi also teaches the use of the use of radiation sensitizers (which read upon a photoinitiator) including phenylketones (Paragraph 69) as well as the use of platinum-group metals for hydrosilylation reactions (Paragraphs 72 and 74). With regard to the viscosity, Kashiwagi teaches that the composition when used for spin coating is typically within a range of 0.1 to 10 Pa·s (Paragraph 101) at a temperature of 25 °C. While 0.1 Pa·s is slightly above the range of the instant claim (0.005 to 0.08), based on the wide range of viscosities disclosed by Kashiwagi depending upon the use case, it stands to reason that the viscosity could be further adjusted in order to meet the requirements of the particular usage, such as switching to inkjet dispensing. Indeed, Kashiwagi notes that additives may be used to adjust the viscosity (Paragraph 81). As such, it would have been obvious to one of ordinary skill in the art to have reduced the viscosity of the composition to be within the range of the instant claim in order to allow for alternate dispensing methods. Regarding the surface tension, while Kashiwagi is silent on the value, Kashiwagi teaches a composition comprised of the same components, and as such, it would necessarily follow that the composition would have the same properties, including surface tension. See MPEP 2112.01.II. Regarding Claim 2, Kashiwagi states that other additives may be used, provided they do not restrict the curability (Paragraph 81). Since a methacrylate not containing a siloxane group would by virtue of the presence of the vinyl group be involved in the curing reaction, it would logically follow that such an additive would not impair the curing process. Additionally, Kashiwagi states that such additional components can be used to reduce viscosity (Paragraph 81). As such, it would have been obvious to have included an acrylate or methacrylate compound as a reactive diluent in the composition. Regarding Claims 3 and 5, Kashiwagi teaches that here are no particular restrictions on method of application to generate a film (Paragraph 100). As Kashiwagi discloses the use of spin coating (Paragraph 100), it would logically follow that the composition can be dispensed as a liquid, and as such, could be adapted to be dispensed as a liquid via inkjet. One of ordinary skill in the art, seeking to reduce waste in the coating process, would seek to find alternate dispensing methods which better utilize the volume of the composition. As such, it would have been obvious to have used the composition via inkjet dispensing. Regarding Claims 4 and 6, Kashiwagi teaches that the composition can be cured via irradiation (Paragraph 94) and heat curing (Paragraph 96). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Kozai (JP 2013-203794) teaches similar compositions to those of the instant application. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ADAM J BERRO whose telephone number is (703)756-1283. The examiner can normally be reached M-F 8:30-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached on 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.J.B./Examiner, Art Unit 1765 /JOHN M COONEY/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Jun 29, 2022
Application Filed
Apr 07, 2025
Non-Final Rejection — §103
Aug 12, 2025
Response Filed
Aug 12, 2025
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12577344
ONE COMPONENT (1K) COMPOSITION BASED ON EPOXY RESIN
2y 5m to grant Granted Mar 17, 2026
Patent 12570883
SEALANT COMPOSITION
2y 5m to grant Granted Mar 10, 2026
Patent 12570802
PERFLUOROPOLYETHER BLOCK-CONTAINING ORGANOHYDROGENPOLYSILOXANE, AND METHOD FOR PRODUCING SAME
2y 5m to grant Granted Mar 10, 2026
Patent 12480019
AMINATED PHOSPHORENE-BASED FLAME-RETARDANT WATERBORNE POLYURETHANE COATING AND PREPARATION METHOD THEREOF
2y 5m to grant Granted Nov 25, 2025
Patent 12421342
CROSSLINKABLE REACTIVE SILICONE ORGANIC COPOLYMERS DISPERSIONS
2y 5m to grant Granted Sep 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
59%
Grant Probability
99%
With Interview (+53.3%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 39 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month